Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impaired Type I IFN Immunity Due to Autoantibodies or a Genetic Defect: a Prospective National Cohort

NCT06762002 is registered in ClinicalTrials.gov with Institut National de la Santé Et de la Recherche Médicale, France as lead sponsor.

NCT NCT06762002
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06762002 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impaired Type I IFN Immunity Due to Autoantibodies or a Genetic Defect: a Prospective National Cohort
Lead sponsor
Institut National de la Santé Et de la Recherche Médicale, France
Phase
Observational
Overall status
Recruiting
Start date
April 9, 2025
Completion date
January 31, 2029
Enrollment
500 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

allergy, genetic diseases, immunology, infectious diseases